EU Lead Generation for US Spin Out Company
Client: A US university spin out
A US University spin out has developed a product to rival antibodies for molecular recognition in diagnostics and therapeutics. The company engaged Fulcrum to generate leads and sales in Europe for the new technology.
The client has developed a new technology but has no mechanism by which to sell outside the United States.
We were engaged to sell the products within the EU. We developed a long list of prospects and currently have seven deals under negotiation for the client of which the total net worth is over US$100,000. Work is ongoing and a pipeline of 250 prospects is being targeted for sales.
The client has deals in negotiation and a number of NDAs in place to facilitate further discussions.
In three months Fulcrum arranged over 25 teleconferences with quality prospects for the client, of which 21 have ongoing potential. A further 20 prospects are looking to enter discussions in the next two months.